Bridgewater Associates (Ray Dalio) — WST Trade History
Quarter-by-quarter changes in the WEST PHARMACEUTICAL SVSC INC position · CUSIP 955306105
Currently held · 3 QFirst seen: 2020 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Reduce | 10,429 | -12,732 | -55.0% | $3.7M | 0.01% |
| 2026 Q1 | 2026-05-15 | Add | 23,161 | 19,088 | +468.6% | $5.8M | 0.03% |
| 2025 Q4 | 2026-02-13 | New | 4,073 | 4,073 | — | $1.1M | 0.00% |
| 2025 Q3 | 2025-11-13 | — | — | — | — | — | — |
| 2025 Q2 | 2025-08-13 | — | — | — | — | — | — |
| 2025 Q1 | 2025-05-14 | — | — | — | — | — | — |
| 2024 Q4 | 2025-02-13 | — | — | — | — | — | — |
| 2024 Q3 | 2024-11-13 | — | — | — | — | — | — |
| 2024 Q2 | 2024-08-14 | Sold out | — | -1,292 | -100.0% | — | — |
| 2024 Q1 | 2024-05-14 | Reduce | 1,292 | -3,101 | -70.6% | $511.3K | 0.00% |
| 2023 Q4 | 2024-02-14 | Reduce | 4,393 | -262 | -5.6% | $1.5M | 0.01% |
| 2023 Q3 | 2023-11-13 | Reduce | 4,655 | -280 | -5.7% | $1.7M | 0.01% |
| 2023 Q2 | 2023-08-11 | Reduce | 4,935 | -30 | -0.6% | $1.9M | 0.01% |
| 2023 Q1 | 2023-05-12 | Reduce | 4,965 | -7,254 | -59.4% | $1.7M | 0.01% |
| 2022 Q4 | 2023-02-13 | Reduce | 12,219 | -29,858 | -71.0% | $2.9M | 0.02% |
| 2022 Q3 | 2022-11-10 | Add | 42,077 | 18,921 | +81.7% | $10.4M | 0.05% |
| 2022 Q2 | 2022-08-11 | Add | 23,156 | 12,266 | +112.6% | $7.0M | 0.03% |
| 2022 Q1 | 2022-05-13 | Add | 10,890 | 2,525 | +30.2% | $4.5M | 0.02% |
| 2021 Q4 | 2022-02-14 | Reduce | 8,365 | -75,708 | -90.1% | $3.9M | 0.02% |
| 2021 Q3 | 2021-11-12 | Reduce | 84,073 | -3,495 | -4.0% | $35.7M | 0.20% |
| 2021 Q2 | 2021-08-13 | Add | 87,568 | 39,073 | +80.6% | $31.4M | 0.20% |
| 2021 Q1 | 2021-05-14 | Add | 48,495 | 6,132 | +14.5% | $13.7M | 0.12% |
| 2020 Q4 | 2021-02-12 | Add | 42,363 | 24,718 | +140.1% | $12.0M | 0.10% |
| 2020 Q3 | 2020-11-13 | New | 17,645 | 17,645 | — | $4.9M | 0.06% |
| 2020 Q2 | 2020-08-12 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-14 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-13 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-13 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-13 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-14 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-13 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-13 | — | — | — | — | — | — |
| 2018 Q1 | 2018-08-13 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-13 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-13 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-13 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-10 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-11 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-10 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-09 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.